MedTrace Logo

Mitigation of Type 2 Diabetes by Partial Ileal Bypass

NCT02493374 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-04-25

No results posted yet for this study

Summary

This is a study of people with type 2 diabetes and high cholesterol between age 18 and 65. This study is trying to figure out if a partial bypass of the small intestine can reverse type 2 diabetes for people who require cholesterol lowering and who cannot tolerate the statin drugs.

Conditions

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    collaborator OTHER

  • Brigham and Women's Hospital

    collaborator OTHER

  • University of Minnesota

    lead OTHER

Principal Investigators

  • Henry Buchwald, MD, PhD · University of Minnesota

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2018-06-30
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02493374 on ClinicalTrials.gov